Scarica l'app Stockscreener
3.21
3.22%
0.10
Dopo l'orario di chiusura:
3.21
Precedente Chiudi:
$3.11
Aprire:
$3.05
Volume 24 ore:
21,876
Relative Volume:
0.74
Capitalizzazione di mercato:
$17.40M
Reddito:
-
Utile/perdita netta:
$-16.35M
Rapporto P/E:
-1.0525
EPS:
-3.05
Flusso di cassa netto:
$-11.88M
1 W Prestazione:
-0.31%
1M Prestazione:
+7.88%
6M Prestazione:
+2.88%
1 anno Prestazione:
-37.12%
Intervallo 1D:
$3.03
$3.21
Intervallo di 1 settimana:
$3.03
$3.2812
Portata 52W:
$2.65
$6.1683
Lipocine Inc Stock (LPCN) Company Profile
Nome
Lipocine Inc
Settore
Industria
Telefono
801 994 7383
Indirizzo
675 ARAPEEN DRIVE, SUITE 202, SALT LAKE CITY, UT
Confronta LPCN con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
LPCN
Lipocine Inc
|
3.21 | 16.85M | 0 | -16.35M | -11.88M | -3.05 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Lipocine Inc Stock (LPCN) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2021-06-24 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-12-10 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2018-01-12 | Reiterato | H.C. Wainwright | Buy |
| 2018-01-11 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2017-12-08 | Ripresa | H.C. Wainwright | Buy |
| 2016-10-07 | Iniziato | H.C. Wainwright | Buy |
| 2015-07-22 | Iniziato | ROTH Capital | Buy |
| 2015-06-23 | Iniziato | Canaccord Genuity | Buy |
Mostra tutto
Lipocine Inc Borsa (LPCN) Ultime notizie
Is Lipocine Inc. stock a safe buy before earningsJuly 2025 Highlights & Daily Stock Trend Watchlist - newser.com
How Lipocine Inc. stock reacts to inflationary pressuresJuly 2025 Weekly Recap & Free Safe Entry Trade Signal Reports - newser.com
How to monitor Lipocine Inc. with trend dashboardsJobs Report & Free AI Powered Buy and Sell Recommendations - newser.com
Multi asset correlation models including Lipocine Inc.Earnings Performance Report & Low Risk Entry Point Tips - newser.com
What moving averages say about Lipocine Inc.Oil Prices & Free Technical Pattern Based Buy Signals - newser.com
Institutional scanner results for Lipocine Inc.2025 Volatility Report & Growth Focused Entry Point Reports - newser.com
Chart overlay techniques for tracking Lipocine Inc.2025 Geopolitical Influence & Safe Investment Capital Preservation Plans - newser.com
Lipocine Inc. stock trend forecastQuarterly Performance Summary & Fast Entry and Exit Trade Plans - newser.com
Is Lipocine Inc. stock trading near support levelsJuly 2025 Reactions & Free Reliable Trade Execution Plans - newser.com
Will Lipocine Inc. bounce back from current supportJuly 2025 Technicals & Accurate Intraday Trading Signals - newser.com
How to manage a losing position in Lipocine Inc.Portfolio Risk Summary & Real-Time Market Sentiment Reports - newser.com
What analysts say about Lipocine Inc stockMarket Sentiment Shifts & Low Entry Investment Ideas - earlytimes.in
How to forecast Lipocine Inc. trends using time seriesOptions Play & Weekly Breakout Watchlists - newser.com
How to track smart money flows in Lipocine Inc.2025 Sector Review & Growth Oriented Trade Recommendations - newser.com
Lipocine Advances Phase 3 Trial for PPD Treatment - MSN
Lipocine Updates Progress on Phase 3 Clinical Trial in Postpartum Depression with LPCN 1154 - Patient Care Online
Lipocine reports one-third enrollment in PPD treatment trial By Investing.com - Investing.com Nigeria
Progress Update: LPCN 1154 for the Treatment of Postpartum Depression - Psychiatric Times
Lipocine provides progress update on LPCN 1154 Phase 3 clinical - MarketScreener
Lipocine reports one-third enrollment in PPD treatment trial - Investing.com India
Lipocine Provides Progress Update on LPCN 1154 Phase 3 Clinical Trial in Postpartum Depression (PPD) - Morningstar
Is Lipocine Inc a good long term investmentSupport Level Holds & Low Cost Stock Picks - earlytimes.in
Lipocine Seeks Regulatory Clarity on LPCN 2401 Study - The Globe and Mail
Lipocine, Inc. Stock Plummets to New 52-Week Low of $2.65 - Markets Mojo
Lipocine, Inc. Hits New 52-Week Low at $2.68 Amid Declining Sales - Markets Mojo
Will Lipocine Inc. rebound enough to break evenBuy Signal & Expert Curated Trade Ideas - newser.com
Volume spikes in Lipocine Inc. stock – what they meanDividend Hike & Proven Capital Preservation Tips - newser.com
Analyzing recovery setups for Lipocine Inc. investorsLayoff News & Long-Term Growth Stock Strategies - newser.com
Long term hold vs stop loss in Lipocine Inc.Rate Hike & Fast Entry Momentum Trade Alerts - newser.com
Hedge Fund Moves: What are the future prospects of Lipocine IncMarket Risk Report & Capital Protection Trade Alerts - خودرو بانک
Custom watchlist performance reports with Lipocine Inc.Quarterly Market Review & Daily Profit Maximizing Trade Tips - newser.com
Block Trades: What is Lipocine Incs revenue forecast2025 Growth vs Value & AI Enhanced Trade Execution Alerts - خودرو بانک
Signal Recap: Will Lipocine Inc benefit from rate cutsWeekly Stock Report & Long Hold Capital Preservation Tips - خودرو بانک
Earnings Report: Is Lipocine Inc stock trending bullishWeekly Stock Analysis & Accurate Intraday Trade Tips - khodrobank.com
Update Report: Does Lipocine Inc have pricing power2025 Trade Ideas & Daily Chart Pattern Signal Reports - خودرو بانک
Lipocine Inc Azioni (LPCN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.15%
1.45%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):